Being consistent with our findings, the strong correlations between high eIF3D expression and poor OS outcomes were also observed in patients with GC [33] and GBC [34], supporting its high potential role to serve as a useful prognostic marker and therapeutic target for the treatment of these cancers. The gene discussed is EIF3D; the disease is cancer.